Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Phone therapy cuts stress in women heart attack survivors

NCT ID NCT02914483

Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether an 8-week telephone stress management program could reduce stress in women who had a heart attack. 153 women with high stress levels were randomly assigned to either the stress management program or enhanced usual care. The program used mindfulness and cognitive-behavioral techniques delivered in group phone sessions. Researchers measured changes in stress, quality of life, and heart-related health over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
telephone-based stress management (mindfulness-based cognitive therapy)
What this could lead to
If it works, this could offer a practical, phone-based way to help women manage stress after a heart attack, improving their quality of life.
What could go wrong
This is a small, completed study focused on stress reduction, not on preventing future heart attacks. The results may not apply to all women or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

153 people

The number who actually took part.

Started

Jan 2017

Finished

Oct 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 to 99 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Acute ischemic symptoms compatible with diagnosis of MI, such as chest pain or anginal equivalent symptoms at rest or new onset exertional anginal equivalent symptoms * Objective evidence of MI (either or both of the following): * Elevation of troponin to above the laboratory upper limit of normal * ST segment elevation of ≥1mm on 2 contiguous ECG leads * Willing to provide informed consent and comply with all aspects of the protocol * Age ≥ 21 years * Female sex * PSS-4 score ≥6 at 2 month follow up visit after MI Exclusion Criteria: * Alternate explanation for troponin elevation, such as hypertensive urgency, acute exacerbation of heart failure, chronic elevation due to kidney disease, pulmonary embolism, cardiac trauma. * Moderately severe or severe depressive symptoms (PHQ-9 ≥ 15) * Active suicidal ideation (PHQ-9 item #9 or otherwise reported during screening) * History of or current diagnosis of psychosis (EHR review) * Significant cognitive impairment (EHR review or evident during screening) * Current participation in another behavioral clinical trial.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Myocardial infarction are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Myocardial infarction

Contacts and locations

Locations

  • Cedars-Sinai Medical Center

    Los Angeles, California, 90048, United States

  • Columbia University Medical Center

    New York, New York, 10032, United States

  • Dartmouth-Hitchcock

    Lebanon, New Hampshire, 03766, United States

  • Emory University

    Atlanta, Georgia, 30322, United States

  • Johns Hopkins Medical Center

    Baltimore, Maryland, 21287, United States

  • NYU Langone Medical Center

    New York, New York, 10016, United States

  • NYU Winthrop

    Mineola, New York, 11501, United States

  • Ohio State University Medical Center

    Columbus, Ohio, 43210, United States

  • Seton Heart (Ascension) - University of Texas, Austin

    Austin, Texas, 78705, United States

  • St. Luke's University Health Network

    Bethlehem, Pennsylvania, 18015, United States

  • Univeristy of Florida

    Gainesville, Florida, 32610, United States

  • University of Alberta

    Edmonton, Alberta, Canada

  • University of Calgary

    Calgary, Canada

  • University of Pittsburgh Medical Center

    Pittsburgh, Pennsylvania, 15213, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.